Cytokeratins and the liver

Alberts B., 1989, Molecular biology of the cell, 613

10.1016/0168-8278(89)90038-X

10.1016/0092-8674(82)90400-7

10.1083/jcb.111.2.567

Steinert P M, 1988, Molecular and cellular biology of intermediate filaments, Ann Rev Biochem, 57, 523, 10.1146/annurev.bi.57.070188.003113

10.1111/j.1432-0436.1986.tb00562.x

10.1016/S0070-2153(08)60097-6

Cooper D., 1985, Biology of disease. Classification of human epithelia and their neoplasms using monoclonal antibodies to keratin, strategies, applications and limitations, Lab Invest, 52, 243

10.1083/jcb.98.4.1388

10.1111/1523-1747.ep12540831

10.1016/0092-8674(85)90098-4

10.1111/j.1749-6632.1985.tb50418.x

10.1007/BF00750732

Osborn M., 1986, Methods in laboratory investigation. Differential diagnosis of gastrointestinal carcinomas by using monoclonal antibodies specific for individual keratin polypeptides, Lab Invest, 55, 497

10.1055/s-2008-1040603

10.1016/0014-4827(81)90234-2

Denk H., 1982, Biochemical and immunocytochemical analysis of the intermediate filament cytoskeleton in human hepatocellular carcinomas and in hepatic neoplastic nodules of mice, Lab Invest, 46, 584

10.1139/o87-071

10.1016/0014-4827(87)90339-9

Phillips M J, 1987, The liver. An atlas and text of ultrastructural pathology, 524

10.1016/0892-0354(89)90009-9

10.1002/hep.1840070608

10.1002/hep.1840080321

Ohta M., 1988, Pathologic changes in the cytokeratin pericanalicular sheath in experimental chloestasis and alcoholic fatty liver, Lab Invest, 59, 60

Marceau N., 1985, Dexamethasone can modulate the synthesis and organization of cytokeratins in cultured differentiating rat hepatocytes, Can J Biochem Cell Biol, 63, 448, 10.1139/o85-064

10.1016/0006-291X(83)90816-1

10.1073/pnas.85.7.2161

10.1016/0277-5379(87)90007-1

10.1016/0014-4827(87)90133-9

10.1007/BF00737080

10.1016/0016-5085(90)91030-A

10.1172/JCI113355

10.1016/0016-5085(89)91696-X

Alpini G., 1989, Bile secretory function of intrahepatic biliary epithelium in the rat, Am J Physiol, 257, G124

10.1111/j.1432-0436.1982.tb01291.x

10.1007/978-1-4613-2299-3_9

Battifora H., 1988, Advances in immunohistochemistry, 191

10.1007/978-3-662-12820-6_1

Marceau N., 1990, Cell lineages and differentiation programs in epidermal, urothelial and hepatic tissues and their neoplasms, Lab Invest, 63, 4

10.1007/BF02624596

Lane E B, 1990, Use of keratin antibodies in tumor diagnosis, Cancer Biol, 1, 165

10.1016/S0140-6736(87)91802-2

Lellis R A, 1986, The use of keratin antibodies in the assessment of rejection in orthotopic liver transplants, Hepatology, 6, 1194

Treem W K, 1991, Cytokeratin immunohistochemical examination of liver biopsies from infants with Alagille syndrome, Gastroenterology, 98, A640

Witzleben C., 1990, Immunohistochemically defined duct element patterns in pediatric liver diseases, Lab Invest, 69, 8P

Eyken P., Molecular and cell biology of the liver

10.1159/000163564

10.1016/0016-5085(89)91695-8

10.1111/j.1600-0676.1990.tb00436.x

Shah K., 1989, Development of intrahepatic bile ducts in humans. Immunohistochemical study using monoclonal cytokeratin antibodies, Arch Pathol Lab Med, 113, 1135

Eyken P., 1990, Phenotypic modulation of hepatocytes: a cytokeratin‐immunohistochemical study, 1

10.1016/0955-0674(90)90153-6

10.1002/hep.1840120530

Shiojiri N., 1991, Cell lineages and oval cell progenitors in rat liver development, Cancer Res, 51, 2611

10.1002/hep.1840080619

Hammara J A., 1926, Über die erste Entstehung der nicht kapillaren intrahepatischen Gallengänge beim Menschen, Z Mikrosk Anat Forsch, 5, 59

Jørgensen M J., 1977, The ductal plate malformation. A study of the intrahepatic bile duct lesion in infantile polycystic disease and congenital hepatic fibrosis, Acta Pathol Microbiol Scand, 257, 1

Germain L., 1988, Biliary epithelial and hepatocyte cell lineage relationships in embryonic rat liver as determined by the differential expression of cytokeratins, alpha‐fetoprotein, albumin and cell surface‐exposed components, Cancer Res, 48, 4909

Eyken P., 1988, Intrahepatic bile duct development in the rat: a cytokeratin‐immunohistochemical study, Lab Invest, 59, 52

10.1111/j.1440-1746.1989.tb00831.x

Eyken P., 1992, The role of cell types in hepatocarcinogenesis, 227

Desmet V J., 1986, Modulation of liver cell expression, 195

Masuko K., 1964, Proliferation of bile ducts in cirrhosis, Arch Pathol, 78, 421

10.1007/BF00724910

10.1016/0014-4800(64)90059-0

Schaffner F., 1961, Electron microscopic studies of normal and proliferated bile ductules, Am J Pathol, 38, 393

10.1016/S0168-8278(85)80752-2

James J., 1989, Application of keratin immunocytochemistry and Sirius red staining in evaluating intrahepatic changes with acute extrahepatic cholestasis due to hepatic duct carcinoma, Hepatogastroenterology, 36, 151

10.1111/j.1365-2559.1989.tb03060.x

10.1111/j.1600-0676.1989.tb00426.x

10.1111/j.1365-2559.1988.tb02092.x

10.1007/BF02890004

10.1007/978-3-642-71837-3_10

Fischer H P, 1987, Keratin polypeptides in malignant epithelial liver tumors, Am J Pathol, 127, 530

10.1016/S0046-8177(88)80205-3

Eyken P., 1991, Immunocytochemistry of cytokeratins in primary human liver tumors, APMIS, 77

10.1002/path.1711560405

10.1097/00000478-198803000-00004

Lai Y‐S, 1989, Expression of cytokeratins in normal and diseased livers and in primary liver carcinomas, Arch Pathol Lab Med, 113, 134

10.1111/j.1365-2559.1990.tb00679.x

Sell S., 1990, Is there a liver stem cell?, Cancer Res, 50, 3811

Sell S., 1989, Evidence for the stem cell origin of hepatocellular carcinoma and cholangiocarcinoma, Am J Pathol, 134, 1347

10.1016/S0046-8177(87)80219-8

10.1016/0046-8177(90)90231-S

Taso M‐S, 1987, Hepatocarcinomas, cholangiocarcinomas, and hepatoblastomas produced by chemically transformed cultured rat liver epithelial cells, Am J Pathol, 127, 168

10.1016/B978-0-12-564504-1.50006-4

10.1111/j.1749-6632.1980.tb29521.x

Lenzi R., 1992, Histogenesis of bile duct‐like cells proliferating during ethionine hepatocarcinogenesis. Evidence for a biliary epithelial nature of oval cells, Lab Invest, 66, 390

10.1002/jcp.1041470220

Thorgeirsson S S, 1992, Cellular and molecular aspects of cirrhosis, 287

Mallory F B., 1911, Cirrhosis of the liver. Five different types of lesions from which it may arise, Bull John Hopkins Hosp, 22, 69

French S W, 1987, Pathogenesis of liver diseases, 95

Yokoo H., 1972, Morphologic variants of alcoholic hyalin, Am J Pathol, 69, 25

Denk H., 1987, Alcoholic liver disease and intermediate filament cytoskeleton, Hepatology Rapid Literature Review, 17, XI

Denk H., 1975, Hepatocellular hyalin (Mallory bodies) in long term griseofulvin‐treated mice: a new experimental model for the study of hyalin formation, Lab Invest, 32, 773

10.1016/S0168-8278(87)80065-X

10.1111/j.1749-6632.1987.tb48680.x

10.1111/j.1530-0277.1990.tb01816.x

French S W., 1983, Present understanding of the development of Mallory's body, Arch Pathol Lab Med, 107, 445

Irie T., 1982, Relationship of Mallory bodies to the cytoskeleton of hepatocytes in griseofulvintreated mice, Lab Invest, 47, 336

Franke W W, 1979, Ultrastructural, biochemical and immunologic characterization of Mallory bodies in livers of griseofulvin‐treated mice. Fimbriated rods of filaments containing prekeratin‐like polypeptides, Lab Invest, 40, 207

10.1002/hep.1840010103

10.1016/S0046-8177(87)80195-8

10.1002/hep.1840080507

Hazan R., 1986, Change of cytokeratin organization during development of Mallory bodies as revealed by a monoclonal antibody, Lab Invest, 54, 543

10.1111/j.1600-0676.1982.tb00194.x

10.1016/0014-5793(81)80994-5

Tinberg H M, 1978, Mallory bodies. Isolation of hepatocellular hyalin and electrophoretic resolution of polypeptide components, Lab Invest, 39, 483

Zatloukal K., 1990, High molecular weight component of Mallory bodies detected by a monoclonal antibody, Lab Invest, 62, 427

Zatloukal K., 1991, High molecular weight components are main constituents of Mallory bodies isolated with a fluorescence activated cell sorter, Lab Invest, 64, 200

Zatloukal K., 1989, Hepatocellular cytokeratins as substrates of transglutaminases, Lab Invest, 61, 603

Zatloukal K., 1992, High amount of (γ‐glutamyl)lysine cross‐links in Mallory bodies, Lab Invest, 66, 774

Ohta M., 1988, Ubiquitin is present on the cytokeratin intermediate filaments and Mallory bodies of hepatocytes, Lab Invest, 59, 848

10.1002/path.1711550105

Vyberg M., 1991, Ubiquitin: an immunohistochemical marker of Mallory bodies and alcoholic liver disease, APMIS, 46

Preisegger K‐H, 1992, Common epitopes of human and murine Mallory bodies and Lewy bodies as revealed by a neurofilament antibody, Lab Invest, 66, 193

Yoshioka K., 1987, Production of monoclonal anti‐Mallory body antibody, Jpn J Gastroenterol, 84, 1251

Yoshioka K., 1989, Occurrence of immunohistochemically detected small Mallory bodies in liver disease, Am J Gastroenterol, 84, 535

10.1111/j.1600-0676.1982.tb00835.x

Kawahara H., 1989, Effect of agents which rearrange the cytoskeleton in vitro on the structure and function of hepatocytic canaliculi, Lab Invest, 60, 692

10.1002/hep.1840110419

10.1002/hep.1840030304

Crespi C., 1986, Segregation of IgA antibodies to cytoskeleton components in patients with alcoholic liver disease, Ital J Gastroenterol, 18, 335

10.1016/0168-8278(90)90119-C

Oda M., 1988, Formation of anti‐cytokeratin antibody in primary biliary cirrhosis: its origin and pathological significance, Hepatology, 8, 1416

Wiedenmann B., 1989, Cytokeratin fragments in serum: possible new markers for the follow‐up of patients with inflammatory liver disease, Gastroenterology, 96, A673

Wiedenmann B., 1989, Cytokeratin fragments – possible additional marker molecules for hepatocellular carcinoma, Gastroenterology, 96, A673

Irie T., 1984, Electron microscopic study of the in vitro calcium‐dependent degradation of Mallory bodies and intermediate filaments in hepatocytes, Lab Invest, 50, 303

Ray M B, 1988, In vitro development of Mallory bodies (MBs) in human hepatoma cells by vitamin A deficiency, Hepatology, 8, 1460

10.1002/hep.1840080507